trending Market Intelligence /marketintelligence/en/news-insights/trending/JS_2no50XZodN2kP28j6nQ2 content esgSubNav
In This List

Kobayashi Pharmaceutical fiscal Q1 profit falls YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


Kobayashi Pharmaceutical fiscal Q1 profit falls YOY

4237919 said its normalized net income for the fiscal first quarter ended June 30 amounted to ¥27.53 per share, a decrease of 13.6% from ¥31.85 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥2.25 billion, a decrease of 13.8% from ¥2.61 billion in the prior-year period.

The normalized profit margin fell to 8.3% from 9.6% in the year-earlier period.

Total revenue totaled ¥27.17 billion, compared with ¥27.21 billion in the year-earlier period, and total operating expenses increased on an annual basis to ¥23.84 billion from ¥23.27 billion.

Reported net income fell 18.5% on an annual basis to ¥2.42 billion, or ¥29.57 per share, from ¥2.96 billion, or ¥36.19 per share.

s of Aug. 6, US$1 was equivalent to ¥102.36.Kobayashi Pharmaceutical Co. Ltd.

4237919 said its normalized net income for the fiscal first quarter ended June 30 amounted to ¥27.53 per share, a decrease of 13.6% from ¥31.85 per share in the year-earlier period.